Perkinelmer Inc (PKI): Alexis P Michas , director of Perkinelmer Inc sold 1,953 shares on Jun 2, 2016. The Insider selling transaction was reported by the company on Jun 3, 2016 to the Securities and Exchange Commission. The shares were sold at $54.85 per share for a total value of $107,122.05 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 26, 2016, Robert F Friel (President and CEO) sold 128,300 shares at $55.01 per share price.On May 12, 2016, Vicki L Sato (director) sold 12,586 shares at $54.27 per share price.Also, On Apr 19, 2016, Daniel R Tereau (officer ) sold 2,158 shares at $50.79 per share price.On Mar 23, 2016, James Corbett (officer ) sold 1,723 shares at $48.74 per share price.
Shares of PerkinElmer (PKI) ended Friday, Jun 3, 2016 session in red amid volatile trading. The shares closed down -0.34 points or -0.62% at $54.58 with 5,16,451 shares getting traded. Post opening the session at $54.8, the shares hit an intraday low of $54.01 and an intraday high of $54.8 and the price vacillated in this range throughout the day. The company has a market cap of $5,951 M and the number of outstanding shares has been calculated to be 10,90,30,445 shares. The 52-week high of PerkinElmer is $56.12 and the 52-week low is $39.5.
On Apr 25, 2016, PerkinElmer announced a cash dividend of $0.0700. The company’s management has announced Jul 13, 2016 as the ex-dividend date and fixed the record date on Jul 15, 2016. The payable date has been fixed on Aug 10, 2016.
Company has been under the radar of several Street Analysts.PerkinElmer is Reiterated by Stifel to Buy and the brokerage firm has raised the Price Target to $ 59 from a previous price target of $51 .The Rating was issued on May 6, 2016.PerkinElmer is Reiterated by Mizuho to Buy and the brokerage firm has raised the Price Target to $ 56 from a previous price target of $52 .The Rating was issued on May 6, 2016.PerkinElmer is Downgraded by BofA/Merrill to Neutral. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Apr 5, 2016.
PerkinElmer Inc. is a provider of products services and solutions to the diagnostics research environmental industrial and laboratory services markets. The Company operates its business in two segments: Human Health and Environmental Health. The Companys Human Health segment concentrates on developing diagnostics tools and applications to help detect diseases earlier and more accurately and to accelerate the discovery and development of new therapies. The Companys Environmental Health segment provides products services and solutions to facilitate the creation of safer food and consumer products more secure surroundings and efficient energy resources. The Company markets its products and services in more than 150 countries.